<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/nport" xmlns:com="http://www.sec.gov/edgar/common" xmlns:ncom="http://www.sec.gov/edgar/nportcommon" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sec.gov/edgar/nport eis_NPORT_Filer.xsd">
  <headerData>
    <submissionType>NPORT-P</submissionType>
    <isConfidential>false</isConfidential>
    <filerInfo>

      <filer>
        <issuerCredentials>
          <cik>0000802716</cik>
          <ccc>XXXXXXXX</ccc>
        </issuerCredentials>
      </filer>


      <seriesClassInfo>
        <seriesId>S000053582</seriesId>
        <classId>C000168414</classId>
        <classId>C000168412</classId>
        <classId>C000168415</classId>
        <classId>C000168413</classId>
      </seriesClassInfo>

    </filerInfo>
  </headerData>
  <formData>
    <genInfo>
      <regName>Victory Portfolios</regName>
      <regFileNumber>811-04852</regFileNumber>
      <regCik>0000802716</regCik>
      <regLei>549300V07N3HJP1EW330</regLei>
      <regStreet1>4900 Tiedeman Road 4th Floor</regStreet1>
      <regCity>Brooklyn</regCity>
      <regStateConditional regCountry="US" regState="US-OH"/>
      <regZipOrPostalCode>44144</regZipOrPostalCode>
      <regPhone>800-539-3863</regPhone>
      <seriesName>Victory RS Science &amp; Technology Fund</seriesName>
      <seriesId>S000053582</seriesId>
      <seriesLei>549300YNZR8S7NDWVW17</seriesLei>
      <repPdEnd>2022-12-31</repPdEnd>
      <repPdDate>2022-06-30</repPdDate>
      <isFinalFiling>N</isFinalFiling>
    </genInfo>
    <fundInfo>
      <totAssets>202011790.44</totAssets>
      <totLiabs>17356116.12</totLiabs>
      <netAssets>184655674.32</netAssets>
      <assetsAttrMiscSec>0.00000000</assetsAttrMiscSec>
      <assetsInvested>0.00000000</assetsInvested>
      <amtPayOneYrBanksBorr>0.00000000</amtPayOneYrBanksBorr>
      <amtPayOneYrCtrldComp>0.00000000</amtPayOneYrCtrldComp>
      <amtPayOneYrOthAffil>0.00000000</amtPayOneYrOthAffil>
      <amtPayOneYrOther>0.00000000</amtPayOneYrOther>
      <amtPayAftOneYrBanksBorr>0.00000000</amtPayAftOneYrBanksBorr>
      <amtPayAftOneYrCtrldComp>0.00000000</amtPayAftOneYrCtrldComp>
      <amtPayAftOneYrOthAffil>0.00000000</amtPayAftOneYrOthAffil>
      <amtPayAftOneYrOther>0.00000000</amtPayAftOneYrOther>
      <delayDeliv>0.00000000</delayDeliv>
      <standByCommit>0.00000000</standByCommit>
      <liquidPref>0.00000000</liquidPref>
      <cshNotRptdInCorD>2114015.37000000</cshNotRptdInCorD>
      <curMetrics>
        <curMetric>
          <curCd>USD</curCd>
          <intrstRtRiskdv01 period10Yr="0.00000000" period1Yr="0.00000000" period30Yr="0.00000000" period3Mon="0.00000000" period5Yr="0.00000000"/>
          <intrstRtRiskdv100 period10Yr="0.00000000" period1Yr="0.00000000" period30Yr="0.00000000" period3Mon="0.00000000" period5Yr="0.00000000"/>
        </curMetric>
      </curMetrics>
      <creditSprdRiskInvstGrade period10Yr="0.00000000" period1Yr="0.00000000" period30Yr="0.00000000" period3Mon="0.00000000" period5Yr="0.00000000"/>
      <creditSprdRiskNonInvstGrade period10Yr="0.00000000" period1Yr="0.00000000" period30Yr="0.00000000" period3Mon="0.00000000" period5Yr="0.00000000"/>
      <borrowers>
        <borrower aggrVal="419326.00000000" lei="549300JRHF1MHHWUAW04" name="NATIONAL FINANCIAL SERVICE LLC"/>
        <borrower aggrVal="0.00000000" lei="KB1H1DSPRFMYMCUFXT09" name="WELLS FARGO BANK NA"/>
        <borrower aggrVal="38360.00000000" lei="549300TDJKVQJ41VN031" name="CIBC WORLD MARKETS INC."/>
        <borrower aggrVal="1249459.00999999" lei="549300KUN9K9K32C6D97" name="BNP PARIBAS PB INTL LTD"/>
        <borrower aggrVal="408600.00000000" lei="L3I9ZG2KFGXZ61BMYR72" name="THE BANK OF NOVA SCOTIA HOU"/>
        <borrower aggrVal="593924.50000000" lei="9R7GPTSO7KV3UQJZQ078" name="MORGAN STANLEY &amp; CO. LLC"/>
        <borrower aggrVal="0.00000000" lei="RUC0QBLBRPRCU4W1NE59" name="BMO CAPITAL MARKETS CORP"/>
        <borrower aggrVal="0.00000000" lei="571474TGEMMWANRLN572" name="STATE STREET BANK AND TRUST CO"/>
        <borrower aggrVal="514488.00000000" lei="ZI8Q1A8EI8LQFJNM0D94" name="PERSHING LLC"/>
        <borrower aggrVal="267518.87999999" lei="RCNB6OTYUAMMP879YW96" name="BNP PARIBAS SECURITIES CORP"/>
        <borrower aggrVal="0.00000000" lei="G5GSEF7VJP5I7OUK5573" name="BARCLAYS BANK PLC"/>
        <borrower aggrVal="0.00000000" lei="58PU97L1C0WSRCWADL48" name="JEFFERIES LLC"/>
        <borrower aggrVal="0.00000000" lei="T6FIZBDPKLYJKFCRVK44" name="UBS SECURITIES LLC"/>
        <borrower aggrVal="0.00000000" lei="BFM8T61CT2L1QCEMIK50" name="UBS AG LONDON"/>
        <borrower aggrVal="5755978.60999999" lei="549300HN4UKV1E2R3U73" name="BOFA SECURITIES  INC."/>
        <borrower aggrVal="135039.10000000" lei="MBNUM2BPBDO7JBLYG310" name="CITIGROUP GLOBAL MARKETS INC"/>
        <borrower aggrVal="536805.00000000" lei="VYVVCKR63DVZZN70PB21" name="WELLS FARGO SECURITIES LLC"/>
        <borrower aggrVal="4661765.31999999" lei="ZBUT11V806EZRVTWT807" name="J.P. MORGAN SECURITIES LLC"/>
        <borrower aggrVal="954217.63999999" lei="AC28XWWI3WIBK2824319" name="BARCLAYS CAPITAL INC"/>
        <borrower aggrVal="0.00000000" lei="MRK678VXOI09YSSN8X19" name="TD AMERITRADE CLEARING INC"/>
      </borrowers>
      <isNonCashCollateral>N</isNonCashCollateral>
      <returnInfo>
        <monthlyTotReturns>
          <monthlyTotReturn classId="C000168414" rtn1="-17.46000000" rtn2="-5.70000000" rtn3="-5.10000000"/>
          <monthlyTotReturn classId="C000168412" rtn1="-17.48000000" rtn2="-5.65000000" rtn3="-5.07000000"/>
          <monthlyTotReturn classId="C000168415" rtn1="-17.42000000" rtn2="-5.66000000" rtn3="-5.07000000"/>
          <monthlyTotReturn classId="C000168413" rtn1="-17.45000000" rtn2="-5.78000000" rtn3="-5.13000000"/>
        </monthlyTotReturns>
        <monthlyReturnCats>
          <equityContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="-4.53000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="-12463.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="-9290.60000000"/>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="-4.53000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="-12463.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="-9290.60000000"/>
            </warrantCategory>
          </equityContracts>
        </monthlyReturnCats>
        <othMon1 netRealizedGain="-411478.28000000" netUnrealizedAppr="-42936125.68000000"/>
        <othMon2 netRealizedGain="-4764789.99000000" netUnrealizedAppr="-7118360.35000000"/>
        <othMon3 netRealizedGain="-7393985.19000000" netUnrealizedAppr="-2297251.47000000"/>
      </returnInfo>
      <mon1Flow redemption="-5960052.56000000" reinvestment="0.00000000" sales="2968021.12000000"/>
      <mon2Flow redemption="-5376171.78000000" reinvestment="0.00000000" sales="2077141.35000000"/>
      <mon3Flow redemption="-3893864.74000000" reinvestment="0.00000000" sales="1455009.36000000"/>

    </fundInfo>
    <invstOrSecs>
      <invstOrSec>
        <name>Krystal Biotech Inc</name>
        <lei>549300YONUY68210OE41</lei>
        <title>KRYSTAL BIOTECH INC</title>
        <cusip>501147102</cusip>
        <identifiers>
          <isin value="US5011471027"/>
        </identifiers>
        <balance>14660.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>962575.60000000</valUSD>
        <pctVal>0.521281354361</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DYNAVAX TECHNOLOGIES CORPORATION</name>
        <lei>549300T5URIXWDILX594</lei>
        <title>DYNAVAX TECHNOLOGIES CORP</title>
        <cusip>268158201</cusip>
        <identifiers>
          <isin value="US2681582019"/>
        </identifiers>
        <balance>54870.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>690813.30000000</valUSD>
        <pctVal>0.374108893508</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="287775.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DermTech Inc</name>
        <lei>N/A</lei>
        <title>DERMTECH INC</title>
        <cusip>24984K105</cusip>
        <identifiers>
          <isin value="US24984K1051"/>
        </identifiers>
        <balance>85743.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>475016.22000000</valUSD>
        <pctVal>0.257244312555</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="476204.84999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AVAYA HOLDINGS CORP.</name>
        <lei>549300NZS2OZN6Q63A60</lei>
        <title>AVAYA HOLDINGS CORP</title>
        <cusip>05351X101</cusip>
        <identifiers>
          <isin value="US05351X1019"/>
        </identifiers>
        <balance>160940.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>360505.60000000</valUSD>
        <pctVal>0.195231260196</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Panacea Acquisition II Corp</name>
        <lei>N/A</lei>
        <title>PANACEA ACQUISITION CORP II</title>
        <cusip>G6882C106</cusip>
        <identifiers>
          <isin value="KYG6882C1069"/>
        </identifiers>
        <balance>188540.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1840150.40000000</valUSD>
        <pctVal>0.996530654569</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1808677.26000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Mirum Pharmaceuticals Inc</name>
        <lei>254900YZKR40F7F27K81</lei>
        <title>MIRUM PHARMACEUTICALS INC</title>
        <cusip>604749101</cusip>
        <identifiers>
          <isin value="US6047491013"/>
        </identifiers>
        <balance>36200.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>704452.00000000</valUSD>
        <pctVal>0.381494910781</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Shattuck Labs Inc</name>
        <lei>N/A</lei>
        <title>SHATTUCK LABS INC</title>
        <cusip>82024L103</cusip>
        <identifiers>
          <isin value="US82024L1035"/>
        </identifiers>
        <balance>130370.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>529302.20000000</valUSD>
        <pctVal>0.286642802583</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Nuvation Bio Inc</name>
        <lei>N/A</lei>
        <title>NUVATION BIO INC WTS</title>
        <cusip>N/A</cusip>
        <identifiers>
          <isin value="US67080N1191"/>
          <other otherDesc="Internal" value="67080N119"/>
        </identifiers>
        <balance>45320.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>12689.60000000</valUSD>
        <pctVal>0.006872033608</pctVal>
        <payoffProfile>N/A</payoffProfile>
        <assetCat>DE</assetCat>
        <issuerConditional desc="WARRANT" issuerCat="OTHER"/>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <derivativeInfo>
          <optionSwaptionWarrantDeriv derivCat="WAR">
            <counterparties>
              <counterpartyName>NYSE MKT LLC</counterpartyName>
              <counterpartyLei>N/A</counterpartyLei>
            </counterparties>
            <putOrCall>Call</putOrCall>
            <writtenOrPur>Purchased</writtenOrPur>
            <descRefInstrmnt>
              <otherRefInst>
                <issuerName>Nuvation Bio Inc</issuerName>
                <issueTitle>NUVATION BIO INC WTS</issueTitle>
                <identifiers>
                  <cusip value="698102209"/>
                  <isin value="US67080N1191"/>
                </identifiers>
              </otherRefInst>
            </descRefInstrmnt>
            <shareNo>45320.00000000</shareNo>
            <exercisePrice>11.50000000</exercisePrice>
            <exercisePriceCurCd>USD</exercisePriceCurCd>
            <expDt>2027-07-07</expDt>
            <delta>XXXX</delta>
            <unrealizedAppr>12689.60000000</unrealizedAppr>
          </optionSwaptionWarrantDeriv>
        </derivativeInfo>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AMAZON.COM, INC.</name>
        <lei>ZXTILKJKG63JELOEG630</lei>
        <title>AMAZON COM INC</title>
        <cusip>023135106</cusip>
        <identifiers>
          <isin value="US0231351067"/>
        </identifiers>
        <balance>62600.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6648746.00000000</valUSD>
        <pctVal>3.600618299158</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BRIDGEBIO PHARMA, INC.</name>
        <lei>54930028YG89VTY2J114</lei>
        <title>BRIDGEBIO PHARMA INC</title>
        <cusip>10806X102</cusip>
        <identifiers>
          <isin value="US10806X1028"/>
        </identifiers>
        <balance>58870.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>534539.60000000</valUSD>
        <pctVal>0.289479108599</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="514488.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sprout Social Inc</name>
        <lei>N/A</lei>
        <title>SPROUT SOCIAL INC</title>
        <cusip>85209W109</cusip>
        <identifiers>
          <isin value="US85209W1099"/>
        </identifiers>
        <balance>16630.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>965704.10000000</valUSD>
        <pctVal>0.522975588785</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alpha Teknova Inc</name>
        <lei>N/A</lei>
        <title>ALPHA TEKNOVA INC</title>
        <cusip>02080L102</cusip>
        <identifiers>
          <isin value="US02080L1026"/>
        </identifiers>
        <balance>53170.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>446628.00000000</valUSD>
        <pctVal>0.241870715126</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PAYCOM SOFTWARE, INC.</name>
        <lei>254900LSB0HNJUDC6Q18</lei>
        <title>PAYCOM SOFTWARE INC</title>
        <cusip>70432V102</cusip>
        <identifiers>
          <isin value="US70432V1026"/>
        </identifiers>
        <balance>12370.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3465084.40000000</valUSD>
        <pctVal>1.876511194557</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Shift4 Payments Inc</name>
        <lei>N/A</lei>
        <title>SHIFT4 PAYMENTS INC CLASS A</title>
        <cusip>82452J109</cusip>
        <identifiers>
          <isin value="US82452J1097"/>
        </identifiers>
        <balance>28210.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>932622.60000000</valUSD>
        <pctVal>0.505060352699</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SNAP INC.</name>
        <lei>549300JNC0L6VP8A2Q35</lei>
        <title>SNAP INC</title>
        <cusip>83304A106</cusip>
        <identifiers>
          <isin value="US83304A1060"/>
        </identifiers>
        <balance>75270.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>988295.10000000</valUSD>
        <pctVal>0.535209710527</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Cara Therapeutics Inc</name>
        <lei>549300COVOY41P0GZ881</lei>
        <title>CARA THERAPEUTICS INC</title>
        <cusip>140755109</cusip>
        <identifiers>
          <isin value="US1407551092"/>
        </identifiers>
        <balance>85200.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>777876.00000000</valUSD>
        <pctVal>0.421257566475</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>RINGCENTRAL, INC.</name>
        <lei>549300C8EH0H1614VE84</lei>
        <title>RINGCENTRAL INC CLASS A</title>
        <cusip>76680R206</cusip>
        <identifiers>
          <isin value="US76680R2067"/>
        </identifiers>
        <balance>6990.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>365297.40000000</valUSD>
        <pctVal>0.197826252209</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CRYOPORT, INC.</name>
        <lei>9845004D8538BT8JF626</lei>
        <title>CRYOPORT INC</title>
        <cusip>229050307</cusip>
        <identifiers>
          <isin value="US2290503075"/>
        </identifiers>
        <balance>48463.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1501383.74000000</valUSD>
        <pctVal>0.813072084315</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>THERAVANCE BIOPHARMA, INC.</name>
        <lei>5493007VTSXP4Z6MIW52</lei>
        <title>THERAVANCE BIOPHARMA INC</title>
        <cusip>G8807B106</cusip>
        <identifiers>
          <isin value="KYG8807B1068"/>
        </identifiers>
        <balance>43570.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>394744.20000000</valUSD>
        <pctVal>0.213773122030</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>APPLOVIN CORPORATION</name>
        <lei>549300LLVXMUAOL3SQ07</lei>
        <title>APPLOVIN CORP</title>
        <cusip>03831W108</cusip>
        <identifiers>
          <isin value="US03831W1080"/>
        </identifiers>
        <balance>46860.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1613858.40000000</valUSD>
        <pctVal>0.873982565628</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1648666.79999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>JPMORGAN PRIME MONEY MARKET FUND</name>
        <lei>N/A</lei>
        <title>JPMorgan Prime Money Market Fund - CJPXX 1.67% 1/31/2020 - Extendable</title>
        <cusip>4812A0367</cusip>
        <identifiers>
          <ticker value="CJPXX"/>
        </identifiers>
        <balance>1978276.27000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1978276.26999999</valUSD>
        <pctVal>1.071332509702</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="1978276.26999999" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>HashiCorp Inc</name>
        <lei>N/A</lei>
        <title>HASHICORP INC</title>
        <cusip>418100103</cusip>
        <identifiers>
          <isin value="US4181001037"/>
        </identifiers>
        <balance>27020.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>795468.80000000</valUSD>
        <pctVal>0.430784920598</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="794445.29999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Marinus Pharmaceuticals Inc</name>
        <lei>549300NCT4OJF7JV1084</lei>
        <title>MARINUS PHARMACEUTICALS INC</title>
        <cusip>56854Q200</cusip>
        <identifiers>
          <isin value="US56854Q2003"/>
        </identifiers>
        <balance>73144.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>354016.96000000</valUSD>
        <pctVal>0.191717347058</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>IAC/INTERACTIVECORP.</name>
        <lei>549300TO56L57RP6P031</lei>
        <title>IAC INTERACTIVECORP</title>
        <cusip>44891N208</cusip>
        <identifiers>
          <isin value="US44891N2080"/>
        </identifiers>
        <balance>14130.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1073456.10000000</valUSD>
        <pctVal>0.581328520747</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Nuvalent Inc</name>
        <lei>N/A</lei>
        <title>NUVALENT INC</title>
        <cusip>670703107</cusip>
        <identifiers>
          <isin value="US6707031075"/>
        </identifiers>
        <balance>44220.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>599623.20000000</valUSD>
        <pctVal>0.324725033340</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="610689.14999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>FATE THERAPEUTICS, INC.</name>
        <lei>549300L14Q4UHOODLA90</lei>
        <title>FATE THERAPEUTICS INC</title>
        <cusip>31189P102</cusip>
        <identifiers>
          <isin value="US31189P1021"/>
        </identifiers>
        <balance>42540.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1054141.20000000</valUSD>
        <pctVal>0.570868565984</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VARONIS SYSTEMS, INC.</name>
        <lei>549300SHIVNRRH7STS26</lei>
        <title>VARONIS SYSTEMS INC</title>
        <cusip>922280102</cusip>
        <identifiers>
          <isin value="US9222801022"/>
        </identifiers>
        <balance>119540.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3504912.80000000</valUSD>
        <pctVal>1.898080204091</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>WIX.COM LTD</name>
        <lei>5493008P6N29Q1AG9464</lei>
        <title>WIX COM LTD</title>
        <cusip>M98068105</cusip>
        <identifiers>
          <isin value="IL0011301780"/>
        </identifiers>
        <balance>16050.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1052077.50000000</valUSD>
        <pctVal>0.569750972383</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IL</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BANDWIDTH INC.</name>
        <lei>549300QC70JB7MUGXM66</lei>
        <title>BANDWIDTH INC</title>
        <cusip>05988J103</cusip>
        <identifiers>
          <isin value="US05988J1034"/>
        </identifiers>
        <balance>36920.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>694834.40000000</valUSD>
        <pctVal>0.376286514107</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>IMPINJ, INC.</name>
        <lei>549300M26VGKSMMWWN17</lei>
        <title>IMPINJ INC</title>
        <cusip>453204109</cusip>
        <identifiers>
          <isin value="US4532041096"/>
        </identifiers>
        <balance>86760.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5090209.20000000</valUSD>
        <pctVal>2.756595061995</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="408600.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Karuna Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>KARUNA THERAPEUTICS INC</title>
        <cusip>48576A100</cusip>
        <identifiers>
          <isin value="US48576A1007"/>
        </identifiers>
        <balance>13330.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1686378.30000000</valUSD>
        <pctVal>0.913255607340</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SiTime Corp</name>
        <lei>N/A</lei>
        <title>SITIME CORP</title>
        <cusip>82982T106</cusip>
        <identifiers>
          <isin value="US82982T1060"/>
        </identifiers>
        <balance>7510.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1224355.30000000</valUSD>
        <pctVal>0.663047753343</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Crinetics Pharmaceuticals Inc</name>
        <lei>549300Q1CNFXK5P31D28</lei>
        <title>CRINETICS PHARMACEUTICALS INC</title>
        <cusip>22663K107</cusip>
        <identifiers>
          <isin value="US22663K1079"/>
        </identifiers>
        <balance>71858.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1340151.70000000</valUSD>
        <pctVal>0.725757117908</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ardelyx Inc</name>
        <lei>549300F542QR4SXHCY32</lei>
        <title>ARDELYX INC</title>
        <cusip>039697107</cusip>
        <identifiers>
          <isin value="US0396971071"/>
        </identifiers>
        <balance>202040.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>119183.40000000</valUSD>
        <pctVal>0.064543589271</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Domo Inc</name>
        <lei>N/A</lei>
        <title>DOMO INC</title>
        <cusip>257554105</cusip>
        <identifiers>
          <isin value="US2575541055"/>
        </identifiers>
        <balance>57360.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1594608.00000000</valUSD>
        <pctVal>0.863557540742</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Omega Alpha SPAC</name>
        <lei>N/A</lei>
        <title>OMEGA ALPHA SPAC</title>
        <cusip>G6749V107</cusip>
        <identifiers>
          <isin value="KYG6749V1077"/>
        </identifiers>
        <balance>90570.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>892114.50000000</valUSD>
        <pctVal>0.483123252662</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="883190.39999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>NVIDIA CORPORATION</name>
        <lei>549300S4KLFTLO7GSQ80</lei>
        <title>NVIDIA CORP</title>
        <cusip>67066G104</cusip>
        <identifiers>
          <isin value="US67066G1040"/>
        </identifiers>
        <balance>16790.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2545196.10000000</valUSD>
        <pctVal>1.378347082683</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PERKINELMER, INC.</name>
        <lei>549300IKL1SDPFI7N655</lei>
        <title>PERKINELMER INC</title>
        <cusip>714046109</cusip>
        <identifiers>
          <isin value="US7140461093"/>
        </identifiers>
        <balance>8310.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1181848.20000000</valUSD>
        <pctVal>0.640028097892</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CHICKEN SOUP FOR THE SOUL ENTERTAINMENT INC.</name>
        <lei>549300THRJ0EJ1DIID72</lei>
        <title>CHICKEN SOUP FOR THE SOUL ENTERTAINMENT INC</title>
        <cusip>16842Q100</cusip>
        <identifiers>
          <isin value="US16842Q1004"/>
        </identifiers>
        <balance>58010.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>429854.10000000</valUSD>
        <pctVal>0.232786835055</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="412132.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>META PLATFORMS, INC.</name>
        <lei>BQ4BKCS1HXDV9HN80Z93</lei>
        <title>META PLATFORMS INC</title>
        <cusip>30303M102</cusip>
        <identifiers>
          <isin value="US30303M1027"/>
        </identifiers>
        <balance>17430.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2810587.50000000</valUSD>
        <pctVal>1.522069392316</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DYNATRACE, INC.</name>
        <lei>N/A</lei>
        <title>DYNATRACE INC</title>
        <cusip>268150109</cusip>
        <identifiers>
          <isin value="US2681501092"/>
        </identifiers>
        <balance>44020.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1736148.80000000</valUSD>
        <pctVal>0.940208746031</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PELOTON INTERACTIVE, INC.</name>
        <lei>5493002YS021166W0339</lei>
        <title>PELOTON INTERACTIVE INC A</title>
        <cusip>70614W100</cusip>
        <identifiers>
          <isin value="US70614W1009"/>
        </identifiers>
        <balance>51930.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>476717.40000000</valUSD>
        <pctVal>0.258165584001</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="485815.05000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kezar Life Sciences Inc</name>
        <lei>549300EV1V8GXBV18004</lei>
        <title>KEZAR LIFE SCIENCES INC</title>
        <cusip>49372L100</cusip>
        <identifiers>
          <isin value="US49372L1008"/>
        </identifiers>
        <balance>170416.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1409340.32000000</valUSD>
        <pctVal>0.763226109996</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Iovance Biotherapeutics Inc</name>
        <lei>N/A</lei>
        <title>IOVANCE BIOTHERAPEUTICS INC</title>
        <cusip>462260100</cusip>
        <identifiers>
          <isin value="US4622601007"/>
        </identifiers>
        <balance>107340.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1185033.60000000</valUSD>
        <pctVal>0.641753146424</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BOOKING HOLDINGS INC.</name>
        <lei>FXM8FAOHMYDIPD38UZ17</lei>
        <title>BOOKING HOLDINGS INC</title>
        <cusip>09857L108</cusip>
        <identifiers>
          <isin value="US09857L1089"/>
        </identifiers>
        <balance>1580.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2763404.20000000</valUSD>
        <pctVal>1.496517347856</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>HSBC US GOVERNMENT MONEY MARKET FUND</name>
        <lei>N/A</lei>
        <title>HSBC US GOVERNMENT MONEY MARKET FUND I SHARES - HGIXX 1.417% 6/22/2022 - Extendable</title>
        <cusip>40428X107</cusip>
        <identifiers>
          <ticker value="HGIXX"/>
        </identifiers>
        <balance>3094312.57000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3094312.57000000</valUSD>
        <pctVal>1.675720273094</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="3094312.57000000" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ICHOR HOLDINGS, LTD.</name>
        <lei>529900PS8R2JVLJ2H892</lei>
        <title>ICHOR HOLDINGS LTD</title>
        <cusip>G4740B105</cusip>
        <identifiers>
          <isin value="KYG4740B1059"/>
        </identifiers>
        <balance>53640.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1393567.20000000</valUSD>
        <pctVal>0.754684200814</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MARVELL TECHNOLOGY, INC</name>
        <lei>N/A</lei>
        <title>MARVELL TECHNOLOGY INC</title>
        <cusip>573874104</cusip>
        <identifiers>
          <isin value="US5738741041"/>
        </identifiers>
        <balance>52300.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2276619.00000000</valUSD>
        <pctVal>1.232899562054</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PMV Pharmaceuticals Inc</name>
        <lei>N/A</lei>
        <title>PMV PHARMACEUTICALS INC</title>
        <cusip>69353Y103</cusip>
        <identifiers>
          <isin value="US69353Y1038"/>
        </identifiers>
        <balance>32310.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>460417.50000000</valUSD>
        <pctVal>0.249338397910</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="209794.56000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DROPBOX, INC.</name>
        <lei>549300JCDF7UAR6TJR51</lei>
        <title>DROPBOX INC</title>
        <cusip>26210C104</cusip>
        <identifiers>
          <isin value="US26210C1045"/>
        </identifiers>
        <balance>131480.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2759765.20000000</valUSD>
        <pctVal>1.494546652932</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>FAIR ISAAC CORPORATION</name>
        <lei>RI6HET5SJUEY30V1PS26</lei>
        <title>FAIR ISAAC CORP</title>
        <cusip>303250104</cusip>
        <identifiers>
          <isin value="US3032501047"/>
        </identifiers>
        <balance>6670.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2674003.00000000</valUSD>
        <pctVal>1.448102263765</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BIOCRYST PHARMACEUTICALS, INC.</name>
        <lei>549300Z0INP1Z5NP6J59</lei>
        <title>BIOCRYST PHARMACEUTICALS INC</title>
        <cusip>09058V103</cusip>
        <identifiers>
          <isin value="US09058V1035"/>
        </identifiers>
        <balance>202960.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2147316.80000000</valUSD>
        <pctVal>1.162876152009</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>GODADDY INC.</name>
        <lei>549300J8H1TB0I2CB447</lei>
        <title>GODADDY INC CLASS A</title>
        <cusip>380237107</cusip>
        <identifiers>
          <isin value="US3802371076"/>
        </identifiers>
        <balance>39920.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2776835.20000000</valUSD>
        <pctVal>1.503790885509</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AMBARELLA INC</name>
        <lei>254900XN7F4DG0CEKC02</lei>
        <title>AMBARELLA INC</title>
        <cusip>G037AX101</cusip>
        <identifiers>
          <isin value="KYG037AX1015"/>
        </identifiers>
        <balance>38090.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2493371.40000000</valUSD>
        <pctVal>1.350281495102</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Relay Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>RELAY THERAPEUTICS INC</title>
        <cusip>75943R102</cusip>
        <identifiers>
          <isin value="US75943R1023"/>
        </identifiers>
        <balance>45550.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>762962.50000000</valUSD>
        <pctVal>0.413181183199</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>TEMPFUND</name>
        <lei>N/A</lei>
        <title>Blackrock Liquidity Funds Temp Fund Portfolio - TMPXX 1.67% 1/30/2020 - Extendable</title>
        <cusip>09248U619</cusip>
        <identifiers>
          <ticker value="TMPXX"/>
        </identifiers>
        <balance>497146.15000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>497146.14999999</valUSD>
        <pctVal>0.269228742539</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="497146.14999999" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MICROSOFT CORPORATION</name>
        <lei>INR2EJN1ERAN0W5ZP974</lei>
        <title>MICROSOFT CORP</title>
        <cusip>594918104</cusip>
        <identifiers>
          <isin value="US5949181045"/>
        </identifiers>
        <balance>70470.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>18098810.10000000</valUSD>
        <pctVal>9.801383123832</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Backblaze Inc</name>
        <lei>N/A</lei>
        <title>BACKBLAZE INC A</title>
        <cusip>05637B105</cusip>
        <identifiers>
          <isin value="US05637B1052"/>
        </identifiers>
        <balance>39210.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>205068.30000000</valUSD>
        <pctVal>0.111054426437</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>2U, INC.</name>
        <lei>5493008RVTXVR43PYF84</lei>
        <title>2U INC</title>
        <cusip>90214J101</cusip>
        <identifiers>
          <isin value="US90214J1016"/>
        </identifiers>
        <balance>158470.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1659180.90000000</valUSD>
        <pctVal>0.898526896674</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SpringWorks Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>SPRINGWORKS THERAPEUTICS INC</title>
        <cusip>85205L107</cusip>
        <identifiers>
          <isin value="US85205L1070"/>
        </identifiers>
        <balance>53550.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1318401.00000000</valUSD>
        <pctVal>0.713978059355</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Singular Genomics Systems Inc</name>
        <lei>N/A</lei>
        <title>SINGULAR GENOMICS SYSTEMS INC</title>
        <cusip>82933R100</cusip>
        <identifiers>
          <isin value="US82933R1005"/>
        </identifiers>
        <balance>113280.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>432729.60000000</valUSD>
        <pctVal>0.234344057713</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="422794.19000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MSILF PRIME PORTFOLIO</name>
        <lei>N/A</lei>
        <title>Morgan Stanley Institutional Liquidity Fund - MPFXX 0.25% 7/31/2020 - Extendable</title>
        <cusip>61747C715</cusip>
        <identifiers>
          <ticker value="MPFXX"/>
        </identifiers>
        <balance>8894716.09000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>8894716.09000000</valUSD>
        <pctVal>4.816919990547</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="8894716.09000000" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VIMEO, INC.</name>
        <lei>N/A</lei>
        <title>VIMEO INC</title>
        <cusip>92719V100</cusip>
        <identifiers>
          <isin value="US92719V1008"/>
        </identifiers>
        <balance>22137.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>133264.74000000</valUSD>
        <pctVal>0.072169317564</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>OPTHEA LIMITED</name>
        <lei>549300Q5FMFDLP46SF83</lei>
        <title>OPTHEA LTD SPON ADR</title>
        <cusip>68386J208</cusip>
        <identifiers>
          <isin value="US68386J2087"/>
        </identifiers>
        <balance>80050.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>504315.00000000</valUSD>
        <pctVal>0.273111022370</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetConditional assetCat="OTHER" desc="ADR"/>
        <issuerCat>CORP</issuerCat>
        <invCountry>AU</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CYTOKINETICS, INCORPORATED</name>
        <lei>549300BE5DY1HW7IHA64</lei>
        <title>CYTOKINETICS INC</title>
        <cusip>23282W605</cusip>
        <identifiers>
          <isin value="US23282W6057"/>
        </identifiers>
        <balance>31040.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1219561.60000000</valUSD>
        <pctVal>0.660451732388</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MAXLINEAR, INC.</name>
        <lei>549300EMOI0SM2IY4F64</lei>
        <title>MAXLINEAR INC CLASS A</title>
        <cusip>57776J100</cusip>
        <identifiers>
          <isin value="US57776J1007"/>
        </identifiers>
        <balance>31030.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1054399.40000000</valUSD>
        <pctVal>0.571008393802</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>LAM RESEARCH CORPORATION</name>
        <lei>549300I4GMO6D34U1T02</lei>
        <title>LAM RESEARCH CORP</title>
        <cusip>512807108</cusip>
        <identifiers>
          <isin value="US5128071082"/>
        </identifiers>
        <balance>6440.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2744406.00000000</valUSD>
        <pctVal>1.486228901498</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DATADOG, INC.</name>
        <lei>549300F6JNO0KRPO1K63</lei>
        <title>DATADOG INC CLASS A</title>
        <cusip>23804L103</cusip>
        <identifiers>
          <isin value="US23804L1035"/>
        </identifiers>
        <balance>15090.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1437171.60000000</valUSD>
        <pctVal>0.778298097414</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY</name>
        <lei>635400GAUMJCLEZRRV50</lei>
        <title>JAZZ PHARMACEUTICALS PLC</title>
        <cusip>G50871105</cusip>
        <identifiers>
          <isin value="IE00B4Q5ZN47"/>
        </identifiers>
        <balance>28000.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4368280.00000000</valUSD>
        <pctVal>2.365635400096</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Monday.Com Ltd</name>
        <lei>N/A</lei>
        <title>MONDAY COM LTD</title>
        <cusip>M7S64H106</cusip>
        <identifiers>
          <isin value="IL0011762130"/>
        </identifiers>
        <balance>15970.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1647465.20000000</valUSD>
        <pctVal>0.892182277131</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IL</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1722499.50000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MATCH GROUP, INC.</name>
        <lei>15OMOPB0A8K0EFUVD031</lei>
        <title>MATCH GROUP INC</title>
        <cusip>57667L107</cusip>
        <identifiers>
          <isin value="US57667L1070"/>
        </identifiers>
        <balance>36366.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2534346.54000000</valUSD>
        <pctVal>1.372471519942</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>HALOZYME THERAPEUTICS, INC.</name>
        <lei>529900242I3SV9AGM753</lei>
        <title>HALOZYME THERAPEUTICS INC</title>
        <cusip>40637H109</cusip>
        <identifiers>
          <isin value="US40637H1095"/>
        </identifiers>
        <balance>39670.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1745480.00000000</valUSD>
        <pctVal>0.945262043220</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>TAKE-TWO INTERACTIVE SOFTWARE, INC.</name>
        <lei>BOMSTHHJK882EWYX3334</lei>
        <title>TAKE TWO INTERACTIVE SOFTWARE</title>
        <cusip>874054109</cusip>
        <identifiers>
          <isin value="US8740541094"/>
        </identifiers>
        <balance>20600.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2524118.00000000</valUSD>
        <pctVal>1.366932269639</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MONOLITHIC POWER SYSTEMS, INC.</name>
        <lei>529900TB7O85LSZ1XU31</lei>
        <title>MONOLITHIC POWER SYSTEMS INC</title>
        <cusip>609839105</cusip>
        <identifiers>
          <isin value="US6098391054"/>
        </identifiers>
        <balance>9350.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3590774.00000000</valUSD>
        <pctVal>1.944578206558</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ALKERMES PUBLIC LIMITED COMPANY</name>
        <lei>N/A</lei>
        <title>ALKERMES PLC</title>
        <cusip>G01767105</cusip>
        <identifiers>
          <isin value="IE00B56GVS15"/>
        </identifiers>
        <balance>41190.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1227050.10000000</valUSD>
        <pctVal>0.664507118191</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SAREPTA THERAPEUTICS, INC.</name>
        <lei>549300IKDPIED8J8IG21</lei>
        <title>SAREPTA THERAPEUTICS INC</title>
        <cusip>803607100</cusip>
        <identifiers>
          <isin value="US8036071004"/>
        </identifiers>
        <balance>17000.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1274320.00000000</valUSD>
        <pctVal>0.690106060749</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>LATTICE SEMICONDUCTOR CORPORATION</name>
        <lei>549300LRBBPZDQ2II567</lei>
        <title>LATTICE SEMICONDUCTOR</title>
        <cusip>518415104</cusip>
        <identifiers>
          <isin value="US5184151042"/>
        </identifiers>
        <balance>74520.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3614220.00000000</valUSD>
        <pctVal>1.957275352251</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SCIENCE 37 INC</name>
        <lei>N/A</lei>
        <title>SCIENCE 37 INC</title>
        <cusip>SC37PIPE1</cusip>
        <identifiers>
          <other otherDesc="Internal" value="SC37PIPE1"/>
        </identifiers>
        <balance>178320.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>358423.20000000</valUSD>
        <pctVal>0.194103539639</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>REGULUS THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>REGULUS THERAPEUTICS INC</title>
        <cusip>75915K309</cusip>
        <identifiers>
          <isin value="US75915K3095"/>
        </identifiers>
        <balance>176848.90000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>366077.22000000</valUSD>
        <pctVal>0.198248562546</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MSILF GOVERNMENT PORTFOLIO</name>
        <lei>N/A</lei>
        <title>MORGAN STANLEY INSTITUTIONAL LIQUIDITY FUNDS - GOVERNMENT PO MUF 0.026% 11/1/2021 - Extendable</title>
        <cusip>61747C707</cusip>
        <identifiers>
          <ticker value="MVRXX"/>
        </identifiers>
        <balance>1319287.03000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1319287.03000000</valUSD>
        <pctVal>0.714457887556</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="1319287.03000000" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DA32 Life Science Tech Acquisition Corp</name>
        <lei>N/A</lei>
        <title>DA32 LIFE SCIENCE TECH ACQUISITION CORP</title>
        <cusip>23312M106</cusip>
        <identifiers>
          <isin value="US23312M1062"/>
        </identifiers>
        <balance>235925.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2286113.25000000</valUSD>
        <pctVal>1.238041158723</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Fusion Pharmaceuticals Inc</name>
        <lei>N/A</lei>
        <title>FUSION PHARMACEUTICALS INC</title>
        <cusip>36118A100</cusip>
        <identifiers>
          <isin value="CA36118A1003"/>
        </identifiers>
        <balance>87990.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>219095.10000000</valUSD>
        <pctVal>0.118650618675</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MKS INSTRUMENTS, INC.</name>
        <lei>549300KEQATBHAGVF505</lei>
        <title>MKS INSTRUMENTS INC</title>
        <cusip>55306N104</cusip>
        <identifiers>
          <isin value="US55306N1046"/>
        </identifiers>
        <balance>35380.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3631049.40000000</valUSD>
        <pctVal>1.966389288263</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SERVICENOW, INC.</name>
        <lei>549300HJTQM36M0E1G39</lei>
        <title>SERVICENOW INC</title>
        <cusip>81762P102</cusip>
        <identifiers>
          <isin value="US81762P1021"/>
        </identifiers>
        <balance>11330.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5387641.60000000</valUSD>
        <pctVal>2.917669126518</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AMICUS THERAPEUTICS, INC.</name>
        <lei>549300MRD1SMUTNBPQ53</lei>
        <title>AMICUS THERAPEUTICS INC</title>
        <cusip>03152W109</cusip>
        <identifiers>
          <isin value="US03152W1099"/>
        </identifiers>
        <balance>37250.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>400065.00000000</valUSD>
        <pctVal>0.216654593189</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Absci Corp</name>
        <lei>N/A</lei>
        <title>ABSCI CORP</title>
        <cusip>00091E109</cusip>
        <identifiers>
          <isin value="US00091E1091"/>
        </identifiers>
        <balance>60310.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>200229.20000000</valUSD>
        <pctVal>0.108433819181</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="29333.87999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Equillium Inc</name>
        <lei>549300OC7SSPSNNGHE64</lei>
        <title>EQUILLIUM INC</title>
        <cusip>29446K106</cusip>
        <identifiers>
          <isin value="US29446K1060"/>
        </identifiers>
        <balance>261851.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>534176.04000000</valUSD>
        <pctVal>0.289282223233</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>GitLab Inc</name>
        <lei>N/A</lei>
        <title>GITLAB INC</title>
        <cusip>37637K108</cusip>
        <identifiers>
          <isin value="US37637K1088"/>
        </identifiers>
        <balance>25560.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1358258.40000000</valUSD>
        <pctVal>0.735562773796</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1351739.68000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kinnate Biopharma Inc</name>
        <lei>549300YVIWV7HJ5WHI66</lei>
        <title>KINNATE BIOPHARMA INC</title>
        <cusip>49705R105</cusip>
        <identifiers>
          <isin value="US49705R1059"/>
        </identifiers>
        <balance>81630.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1029354.30000000</valUSD>
        <pctVal>0.557445257932</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="855812.68000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Inhibrx Inc</name>
        <lei>549300VBKG2LTV1TLY22</lei>
        <title>INHIBRX INC</title>
        <cusip>45720L107</cusip>
        <identifiers>
          <isin value="US45720L1070"/>
        </identifiers>
        <balance>60580.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>687583.00000000</valUSD>
        <pctVal>0.372359529449</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="432839.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Merus NV</name>
        <lei>549300W8GPUWU8QNU293</lei>
        <title>MERUS NV</title>
        <cusip>N5749R100</cusip>
        <identifiers>
          <isin value="NL0011606264"/>
        </identifiers>
        <balance>44920.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1016988.80000000</valUSD>
        <pctVal>0.550748740186</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="982258.86000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Albireo Pharma Inc</name>
        <lei>549300835H8LC7O8VC29</lei>
        <title>ALBIREO PHARMA INC</title>
        <cusip>01345P106</cusip>
        <identifiers>
          <isin value="US01345P1066"/>
        </identifiers>
        <balance>15750.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>312795.00000000</valUSD>
        <pctVal>0.169393657222</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="38360.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>IGM Biosciences Inc</name>
        <lei>5493008XCQES2N0VY969</lei>
        <title>IGM BIOSCIENCES INC</title>
        <cusip>449585108</cusip>
        <identifiers>
          <isin value="US4495851085"/>
        </identifiers>
        <balance>48830.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>880404.90000000</valUSD>
        <pctVal>0.476781936564</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="13350.56000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>WEST PHARMACEUTICAL SERVICES, INC.</name>
        <lei>5493007NKRGM1RJQ1P16</lei>
        <title>WEST PHARMACEUTICAL SERVICES INC</title>
        <cusip>955306105</cusip>
        <identifiers>
          <isin value="US9553061055"/>
        </identifiers>
        <balance>6700.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2025879.00000000</valUSD>
        <pctVal>1.097111695841</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>GOLDMAN SACHS FINANCIAL SQUARE PRIME OBLIGATIONS FUND</name>
        <lei>N/A</lei>
        <title>Goldman Sachs Financial Sq Prime Obligations- FPOXX 0.2% 7/30/2020 - Extendable</title>
        <cusip>38141W364</cusip>
        <identifiers>
          <ticker value="FPOXX"/>
        </identifiers>
        <balance>248100.49000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>248100.49000000</valUSD>
        <pctVal>0.134358443580</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="248100.49000000" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VISA INC.</name>
        <lei>549300JZ4OKEHW3DPJ59</lei>
        <title>VISA INC CLASS A</title>
        <cusip>92826C839</cusip>
        <identifiers>
          <isin value="US92826C8394"/>
        </identifiers>
        <balance>18950.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3731065.50000000</valUSD>
        <pctVal>2.020552855329</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Arco Platform Ltd</name>
        <lei>N/A</lei>
        <title>ARCO PLATFORM LTD</title>
        <cusip>G04553106</cusip>
        <identifiers>
          <isin value="KYG045531061"/>
        </identifiers>
        <balance>52710.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>786960.30000000</valUSD>
        <pctVal>0.426177155344</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="505675.10000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>APELLIS PHARMACEUTICALS, INC.</name>
        <lei>254900HS0ZFRXXSB9D42</lei>
        <title>APELLIS PHARMACEUTICALS INC</title>
        <cusip>03753U106</cusip>
        <identifiers>
          <isin value="US03753U1060"/>
        </identifiers>
        <balance>36453.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1648404.66000000</valUSD>
        <pctVal>0.892691040267</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Intra-Cellular Therapies Inc</name>
        <lei>5299002U2KGF193IJA20</lei>
        <title>INTRA CELLULAR THERAPIES INC</title>
        <cusip>46116X101</cusip>
        <identifiers>
          <isin value="US46116X1019"/>
        </identifiers>
        <balance>59250.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3381990.00000000</valUSD>
        <pctVal>1.831511548428</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>APPLIED MATERIALS, INC.</name>
        <lei>41BNNE1AFPNAZELZ6K07</lei>
        <title>APPLIED MATERIALS INC</title>
        <cusip>038222105</cusip>
        <identifiers>
          <isin value="US0382221051"/>
        </identifiers>
        <balance>20920.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1903301.60000000</valUSD>
        <pctVal>1.030730091024</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ZoomInfo Technologies Inc</name>
        <lei>N/A</lei>
        <title>ZOOMINFO TECHNOLOGIES INC A</title>
        <cusip>98980F104</cusip>
        <identifiers>
          <isin value="US98980F1049"/>
        </identifiers>
        <balance>38520.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1280404.80000000</valUSD>
        <pctVal>0.693401274948</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.</name>
        <lei>N/A</lei>
        <title>MACOM TECHNOLOGY SOLUTIONS HOL</title>
        <cusip>55405Y100</cusip>
        <identifiers>
          <isin value="US55405Y1001"/>
        </identifiers>
        <balance>129340.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5962574.00000000</valUSD>
        <pctVal>3.229022894615</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VEEVA SYSTEMS INC.</name>
        <lei>549300YZEXPDB92M2F02</lei>
        <title>VEEVA SYSTEMS INC</title>
        <cusip>922475108</cusip>
        <identifiers>
          <isin value="US9224751084"/>
        </identifiers>
        <balance>9260.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1833850.40000000</valUSD>
        <pctVal>0.993118899136</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kura Oncology Inc</name>
        <lei>5493005QORQTZCZYOP39</lei>
        <title>KURA ONCOLOGY INC</title>
        <cusip>50127T109</cusip>
        <identifiers>
          <isin value="US50127T1097"/>
        </identifiers>
        <balance>40300.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>738699.00000000</valUSD>
        <pctVal>0.400041321622</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vaxcyte Inc</name>
        <lei>254900M7NMHTGASX8D95</lei>
        <title>VAXCYTE INC</title>
        <cusip>92243G108</cusip>
        <identifiers>
          <isin value="US92243G1085"/>
        </identifiers>
        <balance>50710.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1103449.60000000</valUSD>
        <pctVal>0.597571455122</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>TRICIDA, INC.</name>
        <lei>549300QVPFFJC8SZXG25</lei>
        <title>TRICIDA INC</title>
        <cusip>89610F101</cusip>
        <identifiers>
          <isin value="US89610F1012"/>
        </identifiers>
        <balance>115340.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1116491.20000000</valUSD>
        <pctVal>0.604634113796</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="625264.63999999"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VERTEX PHARMACEUTICALS INCORPORATED</name>
        <lei>54930015RAQRRZ5ZGJ91</lei>
        <title>VERTEX PHARAMACEUTICALS INC</title>
        <cusip>92532F100</cusip>
        <identifiers>
          <isin value="US92532F1003"/>
        </identifiers>
        <balance>37520.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10572760.80000000</valUSD>
        <pctVal>5.725662554879</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>REGULUS THERAPEUTICS WRT</name>
        <lei>N/A</lei>
        <title>REGULUS THERAPEUTICS WRT</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Internal" value="RGLSPPIPE"/>
        </identifiers>
        <balance>1326367.0000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>0.01</valUSD>
        <pctVal>0.000000005415</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>Y</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
    </invstOrSecs>
    <explntrNotes>
      <explntrNote note="Monthly total returns reported under item B.5.a do not include any sales or redemption charges, as applicable." noteItem="B.5.a"/>
      <explntrNote note="Securities on loan in Part C.12 does not include shares sold prior to June 30, 2022." noteItem="C.12.c"/>
    </explntrNotes>
    <signature>
      <ncom:dateSigned>2022-08-01</ncom:dateSigned>
      <ncom:nameOfApplicant>Victory Portfolios</ncom:nameOfApplicant>
      <ncom:signature>Allan Shaer</ncom:signature>
      <ncom:signerName>Allan Shaer</ncom:signerName>
      <ncom:title>Treasurer</ncom:title>
    </signature>
  </formData>
</edgarSubmission>
